BUZZ-Truist Securities downgrades Penumbra on Boston Scientific's $14.5 billion buyout** Truist Securities downgrades medical equipment maker Penumbra PEN.N to "hold" from "buy"
** Boston Scientific BSX.N said on Thursday that it will buy PEN in a deal valued at about $14.5 billion
** We don't see any major hurdles to this deal closing and believe it will be hard to top BSX given the smooth strategic fit, brokerage says
** 11 of 19 brokerages rate the stock "buy" and 8 "hold"; their median PT is $370
** Including session's move, PEN up 34% in the last 12 months
(Reporting by Pragyan Kalita in Bengaluru)
((Pragyan.Kalita@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments